Large-scale testing (Phase 3)Study completedNCT01880424
What this trial is testing
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Who this might be right for
Irritable Bowel Syndrome With Constipation (IBS-C)
AstraZeneca 1,722